Official Listing of Recbio on HKEX, Vaccine Innovation and Iteration Accelerated by Novel Adjuvant Technology
HONG KONG, Apr 1, 2022 – (ACN Newswire via SEAPRWire.com) – On March 31, the China-based novel vaccines company – Jiangsu Recbio Technology Co., Ltd. (“Recbio” or the “Company”, Stock […]